BGM Group Ltd. (BGM) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of BGM Group Ltd. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGM
BGM Group Ltd.
$9.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BGM vs PYXS
growth of $100 · dividends reinvested · last 2yBGM -94.3% (-76.2%/yr)PYXS -31.1% (-17.0%/yr)PYXS compounded faster over this window
Log scale — wide-divergence pair
BGM PYXS
BGM vs PYXS: by the numbers
- •PYXS is the larger company ($128M vs $122M market cap).
- •Both run net losses; BGM's is the smaller (-52.59% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | BGM | PYXS |
|---|---|---|
| P/S ratio | N/A | 11.59 |
| P/B ratio | 0.31 | 11.19 |
Profitability
| Metric | BGM | PYXS |
|---|---|---|
| Gross margin | 12.79% | 82.77% |
| Operating margin | -33.18% | -609.18% |
| Net margin | -52.59% | -803.83% |
| ROE | -5.10% | -775.59% |
| ROIC | -3.19% | -314.66% |
Growth (annualized)
| Metric | BGM | PYXS |
|---|---|---|
| Revenue CAGR (5Y) | -5.39% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.